Suppr超能文献

使用两亲性聚合物的非晶态纳米分散体提高非洛地平的溶出度:深入了解药物-聚合物相互作用对药物溶出的作用。

Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution.

作者信息

Pandey Murali Monohar, Jaipal A, Charde Shrikant Y, Goel Puneet, Kumar Love

机构信息

a Industrial Research Laboratory, Department of Pharmacy , Birla Institute of Technology & Science , Pilani , Rajasthan , India and.

b Department of Pharmacy , Birla Institute of Technology and Science , Pilani, Hyderabad , Andhra Pradesh , India.

出版信息

Pharm Dev Technol. 2016;21(4):463-74. doi: 10.3109/10837450.2015.1022785. Epub 2015 Mar 17.

Abstract

CONTEXT

Felodipine, a poorly soluble drug, is widely used in the treatment of angina pectoris and hypertension.

OBJECTIVE

This study aimed at the preparation of amorphous solid dispersion (SD) of felodipine using an amphiphilic polymer, soluplus, for the potential enhancement in solubility of the drug.

MATERIALS AND METHODS

Solid dispersions with varying proportions of drug and soluplus were prepared and the rate and extent of dissolution from SDs was compared with that of the pure drug. FT-IR and (1)H NMR spectroscopic analysis were carried out to examine the formation mechanism of SDs. Various techniques were used for solid state characterization of designed SDs.

RESULTS

Formation of amorphous solid dispersions with particle size in nanometer range indicated suitability of polymer and method used in the preparation. FT-IR and (1)H NMR spectroscopy revealed that soluplus was involved in strong hydrogen bonding with felodipine molecules which resulted in the conversion of crystalline felodipine into amorphous form. Solid dispersion with 1:10 drug/polymer ratio showed more than 90% drug dissolution in 30 min whereas pure felodipine showed less than 19% drug dissolution in 1 h.

DISCUSSION AND CONCLUSION

Amorphous SDs of felodipine were prepared using soluplus resulting in substantial enhancement in the rate and extent of dissolution of felodipine.

摘要

背景

非洛地平是一种难溶性药物,广泛用于治疗心绞痛和高血压。

目的

本研究旨在使用两亲性聚合物尤特奇(Soluplus)制备非洛地平的无定形固体分散体(SD),以潜在提高药物的溶解度。

材料与方法

制备了不同药物与尤特奇比例的固体分散体,并将其溶出速率和程度与纯药物进行比较。进行了傅里叶变换红外光谱(FT-IR)和核磁共振氢谱(¹H NMR)分析以研究固体分散体的形成机制。采用多种技术对设计的固体分散体进行固态表征。

结果

形成了粒径在纳米范围内的无定形固体分散体,表明聚合物及制备方法的适用性。FT-IR和¹H NMR光谱显示尤特奇与非洛地平分子形成了强氢键,导致结晶态非洛地平转变为无定形。药物/聚合物比例为1:10的固体分散体在30分钟内药物溶出率超过90%,而纯非洛地平在1小时内药物溶出率低于19%。

讨论与结论

使用尤特奇制备了非洛地平无定形固体分散体,显著提高了非洛地平的溶出速率和程度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验